Another Production Line With An Annual Output Of 500 Tons Of Melt Spray Cloth Has Been Put Into Operation In Lanzhou, Gansu.

The Gansu Engineering Consulting Group Limited by Share Ltd (hereinafter referred to as "Gan consulting") announced in the evening of April 16th that the company's share of Lanzhou Gem Flower Medical Equipment Co., Ltd. (hereinafter referred to as "Gem Flower Company") has an annual output of 500 tons / year of a meltblown fabric production line has been completed and formally put into operation, and another production line is accelerating.

Previously reported, Gan consulting invested 2 million yuan, shares 10% Gem Flower medical device investment in the construction of medical masks and melt blown non-woven production projects, the project has 1 medical mask production lines (N95) and 4 disposable medical mask production lines on the basis of the newly built 2 melted spray production lines, and is expected to produce 40 million disposable medical masks after the normal production. Medical mask (N95) 6 million, annual melt melt cloth 1000 tons.

Reporters checked the data at night today and found that the registered address of Gem Flower medical device is located at 152 Xigu Middle Road, Xigu District, Lanzhou, Gansu, -10, which covers the production and sale of disposable masks, medical masks, medical textiles, and sales of medical devices.

According to Gan consultancy, the development of masks and medical textile production lines based on PetroChina Lanzhou Petrochemical Company and its subsidiaries will be beneficial to the supply of epidemic prevention and control materials and meet the demand for medical masks and melt blown nonwoven materials in the following markets.

It is reported that after this year's outbreak, health care workers and ordinary residents have stepped up protection. The demand for medical and civil protective masks has increased sharply, and domestic textile and garment enterprises have increased the production of masks and protective clothing. In March, new crowns and pneumonia cases broke out in Europe, the United States and other regions, further increased the consumption of protective products, and intensified the import of masks, protective clothing and other protective materials from China. Recently, the State Council press conference data show that as of April 5th, the domestic medical N95 mask has more than 3 million 400 thousand capacity per day.

The demand for masks increased rapidly, resulting in a rapid growth in the demand for melt blown nonwovens, but constrained by the slow expansion of production capacity, the long delivery cycle, and the slow expansion of melt blown nonwovens. The Sinopec started building 16 melted spray production lines in February, and it can be used to produce more than 10 billion disposable medical masks annually, and the production of protective clothing requires the use of spunbonded nonwoven fabrics. It is necessary to use Spunlaced Nonwovens for the production of toxic bactericidal wipes and wipe fabrics. The demand for protective clothing and disinfectant wipes increased after the outbreak of the disease, and the consumption of corresponding nonwoven products increased accordingly. As spunbonded and spunlaced nonwoven fabrics are relatively abundant, their prices are relatively stable.

Everbright Securities analyst Li Jie said that in the short term, the epidemic will catalyze spunlace, melt blown and other non-woven fabric demand. In the long run, China's non-woven industry also has great room for development. From the perspective of industrial structure, the proportion of industrial fiber textile processing accounts for more than 40% of the textile industry in Europe and the United States. In 2018, China accounted for more than 27% of industrial textiles, and the future nonwoven industry still has great potential for development.

In Li Jie's view, as far as consumption level is concerned, because of the difference in income and consumption level, compared with the developed countries, China's per capita non-woven consumption is at a low level. As we all know, the largest application area of China's nonwovens is medical and health care. In 2016, the consumption of Medical Nonwovens in China was 1 million 461 thousand and 600 tons, accounting for 27.3%, while 60%~70% in the US market was non-woven. It is used for medical and health supplies and daily necessities. In Japan, non-woven fabrics consumed by industrial, medical and sanitary supplies account for 57.4% of the demand. Due to the high use cost, the proportion of China's disposable protective non-woven products is far lower than that of the developed countries. The short-term epidemic increases the demand for protective products. In the long run, the consumption of medical nonwovens is expected to continue to grow, and the rapid development of medical non-woven materials manufacturing enterprises will be promoted.

Public information shows that Gan consulting was formerly Lanzhou Sanmao industrial Limited by Share Ltd (hereinafter referred to as "Sanmao sends the gods"), Sanmao completed the major asset reorganization in 2018, and in May 2019, the company transferred the 100% stake of Lanzhou Sanmao Industrial Co., Ltd. to the controlling shareholder. The equity assets delivery has been fulfilled and the wool textile business has been stripped. The main business of the company is transformed from the double main business of wool spinning and engineering consulting service to the single main business of the engineering consulting service industry.

Gan consulting is mainly engaged in planning, survey, design, consulting, testing, supervision, cost, bidding agency, project management and other technical services, business covers housing construction, water conservancy and hydropower, municipal, transportation and other fields, in the industry has a certain market position and brand awareness.

According to the financial report, in 2019, Gan consulting achieved a business income of 2 billion 138 million yuan, an increase of 1.11% over the same period last year, achieving a net profit of 301 million yuan attributable to shareholders, an increase of 26.68% over the same period last year, achieving a profit of 0.819 yuan per share, an increase of 31.30% over the same period last year.

From the perspective of business structure, "survey and design" is the main source of business revenue. Specifically, the "survey and design" business revenue is 690 million, revenue accounted for 32.4%, gross margin of 39.3%.